Newsroom

Mar 11

<�鶹��ý��Ƶ class="item-list__title"> United in Blue in Washington, D.C.

ASGE joined partners all around the country yesterday to contribute to the power of speaking in one voice to promote colorectal cancer awareness.

Mar 04

<�鶹��ý��Ƶ class="item-list__title"> Evidence-Based Strategies Improve Colonoscopy Bowel Preparation Quality, Performance, and Patient Experience

Three U.S. Gastroenterology Societies Jointly Publish Updated Consensus Recommendations

Feb 25

<�鶹��ý��Ƶ class="item-list__title"> 33 Patient and Medical Professional Organizations File Amicus Brief Urging the US Supreme Court to Protect Lifesaving Preventive Care Without Patient Cost Sharing

Today, 33 organizations representing millions of patients with serious health conditions and thousands of health care professionals filed an amicus brief in the U.S. Supreme Court case Braidwood Management v. Kennedy.

Feb 03

<�鶹��ý��Ƶ class="item-list__title"> Nomination Period Opens for Key Leadership Programs

The nomination period for the 2025 LEAD and GOLD leadership development programs is officially open.

Dec 23

<�鶹��ý��Ƶ class="item-list__title"> Congress Adjourns Without Stopping Physician Pay Cut

On December 20, Congress passed a short-term spending bill that does not include relief for physicians from a 2.83 percent Medicare payment cut that will take effect January 1.

Dec 18

<�鶹��ý��Ƶ class="item-list__title"> ASGE Efforts Pay Off: Lawmakers Agree to Curb Harmful Physician Pay Cut

ASGE Efforts Pay Off: Lawmakers Agree to Curb Harmful Physician Pay Cut

Dec 06

<�鶹��ý��Ƶ class="item-list__title"> ASGE Joins Fight CRC-Led Initiative to Advance Bold Colorectal Cancer Care Goals

ASGE has joined the Colorectal Cancer Care Initiative (CRCCI), a multi-stakeholder effort designed by Fight Colorectal Cancer! (Fight CRC) to improve colorectal cancer (CRC) screening, diagnosis and treatment in significant ways.

Nov 22

<�鶹��ý��Ƶ class="item-list__title"> Success: GI societies push BCBS to rescind proposed biosimilar policy

Blue Cross Blue Shield (BCBS) will not move forward with changes to its medical policy guideline “Infliximab Biosimilar Step Therapy Requirements” (Policy Number RX501.051)

Nov 06

<�鶹��ý��Ƶ class="item-list__title"> CMS Finalizes Unacceptable 2.83 Percent Cut to Physician Payments in 2025

GI Societies are fighting to prevent reimbursement cuts – you can help!

Oct 11

<�鶹��ý��Ƶ class="item-list__title"> NEW IV Fluid Shortage Resource Page

ASGE is closely monitoring IV fluid supply following interruptions in manufacturing as a result of Hurricane Helene.